These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 19665247)

  • 41. Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the future.
    Di Martino V; Richou C; Cervoni JP; Sanchez-Tapias JM; Jensen DM; Mangia A; Buti M; Sheppard F; Ferenci P; Thévenot T
    Hepatology; 2011 Sep; 54(3):789-800. PubMed ID: 21674553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: a meta-analysis.
    Deltenre P; Louvet A; Lemoine M; Mourad A; Fartoux L; Moreno C; Henrion J; Mathurin P; Serfaty L
    J Hepatol; 2011 Dec; 55(6):1187-94. PubMed ID: 21703195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
    Bacon BR; Shiffman ML; Mendes F; Ghalib R; Hassanein T; Morelli G; Joshi S; Rothstein K; Kwo P; Gitlin N
    Hepatology; 2009 Jun; 49(6):1838-46. PubMed ID: 19291790
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Study on retreatment of CHC patients with initial treatment failure].
    Zhang L; Shen G; Zhang YL; Qiu GH; Lu Y; Zhao H; Yang M; Li MH; Xie Y; Cheng J; Xu DZ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):304-6. PubMed ID: 23189852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Retreatment of chronic hepatitis C in previous non-responders and relapsers.
    Satoskar R; Jensen DM
    Expert Opin Pharmacother; 2007 Oct; 8(15):2491-503. PubMed ID: 17931085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: a meta-analysis.
    Cammà C; Cabibbo G; Bronte F; Enea M; Licata A; Attanasio M; Andriulli A; Craxì A
    J Hepatol; 2009 Oct; 51(4):675-81. PubMed ID: 19665247
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Update on the treatment of patients with non-genotype 1 hepatitis C virus infection.
    Mangia A; Mottola L; Piazzolla V
    Clin Infect Dis; 2013 May; 56(9):1294-300. PubMed ID: 23271787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Retreatment strategies for the patients with HCV infection].
    Pawłowska M
    Przegl Epidemiol; 2005; 59(2):591-4. PubMed ID: 16190570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Retreatment of patients who do not respond to initial therapy for chronic hepatitis C.
    Shiffman ML
    Cleve Clin J Med; 2004 May; 71 Suppl 3():S13-6. PubMed ID: 15468612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon mono-therapy for symptomatic HCV-associated mixed cryoglobulinemia : meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Messa P
    Acta Gastroenterol Belg; 2013 Dec; 76(4):363-71. PubMed ID: 24592538
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is sustained virological response a marker of treatment efficacy in patients with chronic hepatitis C viral infection with no response or relapse to previous antiviral intervention?
    Gurusamy KS; Wilson E; Koretz RL; Allen VB; Davidson BR; Burroughs AK; Gluud C
    PLoS One; 2013; 8(12):e83313. PubMed ID: 24349487
    [TBL] [Abstract][Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.